摘要
目的探讨子宫内膜异位症患者保守手术后口服屈螺酮炔雌醇(优思明)及放置左炔诺孕酮宫内缓释系统(曼月乐)的临床疗效。方法选取2014年2月至2016年6月在江门市中心医院妇科腹腔镜保守手术的子宫内膜异位症的患者110例,随机分为优思明治疗组和曼月乐治疗组,6个月后观察两组患者在治疗前及治疗后痛经程度、月经量、子宫体积及检测CA125水平变化,并记录不良反应情况。结果两组患者治疗后与治疗前相比,VAS疼痛评分、月经量及CA125水平均较治疗前显著降低(曼月乐组:t值分别为4.39、6.69、6.87,均P<0.05;优思明组:t值分别为4.65、7.64、6.86,均P<0.05),而且采用曼月乐或优思明不同的治疗方法,对痛经缓解、月经改善、子宫体积缩小、CA125下降均表现出相似的效果,两组之间比率无显著性差异(χ2值分别为1.45、2.67、1.26、2.86,均P>0.05)。曼月乐组阴道异常流血发生率55.17%,较优思明组(16.67%)明显升高(χ2=7.87,P<0.05)。结论优思明及曼月乐对子宫内膜异位症的治疗均有一定疗效,可根据患者的具体情况选择性地选用治疗方案。
Objective To investigate the clinical effects of oral intrautedrine system(Mirena) in patients with endometriosis endometriosis underwent conservative surgery of gynecologic drospirenone-ethinylestradiol (Yasmin) and levonorgestrel releasing after conservative surgery. Methods A total of 110 patients with laparoscopic surgery in Jiangmen Central Hospital from February 2014 to June 2016, and they were randomly divided into Yasmin group and Mirena group. The levels of dysmenorrhea, menstrual blood volume, uterine volume and CA125 were measured before and six months after treatment. And the adverse reactions were recorded. Results VAS pain score, menstrual blood volume and CA125 level of two groups decreased significantly after treatment (t value was 4.39, 6.69 and 6.87, respectively in Mirena group, t value was 4.65, 7.64 and 6.86, respectively in Yasmin group, all P〈0.05). The effect on relieving dysmenorrhea, improving menstruation, shrink of uterine volume and CA 125 decreasing was similar between two methods, and the differences between two groups were not significant (χ2 value was 1.45, 2.67, 1.26 and 2.86, respectively, all P〉0.05). The incidence of abnormal vaginal bleeding was 55.71 % in Mirena group, which was remarkably higher than that (16.67 %) in Yasmin group (χ2= 7.87, P 〈0.05). Conclusion Yasmin and Mirenaon have certain effect on treatment of endometriosis, and treatment programs can be selected according to specific circumstances of patients.
作者
王海清
胡杏军
刘芳
王嵘
詹雪梅
WANG Hai-qing;HU Xing-jun;LIU Fang;WANG Rong;ZHAN Xue-mei(Department of Gynecology, Jiangmen City Center Hospital, Guangdong Jiangmen 529030, Chin)
出处
《中国妇幼健康研究》
2018年第5期652-655,共4页
Chinese Journal of Woman and Child Health Research
关键词
子宫内膜异位症
屈螺酮炔雌醇
左炔诺孕酮宫内缓释系统
痛经
endometriosis (EMs)
drospirenone-ethinylestradiol
levonorgestrel releasing intrauterine system (LNG-IUS) dysmenorrhea